Abb J, Abb H, Deinhardt F
Int J Cancer. 1982 Jan 15;29(1):77-80. doi: 10.1002/ijc.2910290113.
We describe the production of marmoset lymphoblastoid cell interferon (IFN). Optimal yields of IFN were obtained when EBV-transformed lymphoblastoid cell lines (LCL) at a cell density of 1 X 10(6)/ml were incubated with 100 HAU Sendai virus/ml for 24 h. Sendai-virus-induced marmoset lymphoblastoid cell IFN was acid-stable and exerted antiviral activity on both homologous and heterologous human cells, thus allowing its classification as IFN alpha. Marmoset lymphoblastoid cell IFN did not inhibit the growth of herpesvirus-transformed marmoset T-or B-cell lines, but markedly enhanced marmoset NK-cell activity against human myeloid leukemia target cells. The use of lymphoblastoid cell IFN in marmosets in vivo may contribute to an understanding of the pathogenic role of IFN in herpesvirus-induced lymphoproliferative diseases.
我们描述了狨猴淋巴母细胞样细胞干扰素(IFN)的产生。当细胞密度为1×10⁶/ml的EB病毒转化的淋巴母细胞样细胞系(LCL)与100血凝单位(HAU)/ml的仙台病毒孵育24小时时,可获得最佳产量的IFN。仙台病毒诱导的狨猴淋巴母细胞样细胞IFN对酸稳定,并对同源和异源人类细胞均具有抗病毒活性,因此可将其归类为IFNα。狨猴淋巴母细胞样细胞IFN不抑制疱疹病毒转化的狨猴T或B细胞系的生长,但能显著增强狨猴自然杀伤(NK)细胞对人髓系白血病靶细胞的活性。在狨猴体内使用淋巴母细胞样细胞IFN可能有助于了解IFN在疱疹病毒诱导的淋巴增殖性疾病中的致病作用。